D
Cidara Therapeutics, Inc. CDTX
$22.54 -$0.46-2.00%
Recommendation
Sell
Prev Close
$23.00
Volume
15,457
Avg Vol (90D)
90,123
Market Cap
$251.93M
Dividend & Yield
--
52-Week Range
$10.00 - $28.42
P/E (TTM)
--
EPS (TTM)
-$25.43
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Very Weak
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Cidara Therapeutics (CDTX, $23) entered Uptrend as Momentum indicator ascends above 0 level on Mar 12, 2025
3/13/2025 - Tickeron - Stocks
HC Wainwright Raises Cidara Therapeutics (NASDAQ:CDTX) Price Target to $35.00
3/13/2025 - Ticker Report
Cidara Therapeutics (NASDAQ:CDTX) Now Covered by Analysts at Citizens Jmp
3/12/2025 - MarketBeat
Cidara Therapeutics (CDTX, $21) entered Downtrend as Momentum indicator drops below 0 level on Mar 11, 2025
3/12/2025 - Tickeron - Stocks
Cidara Therapeutics initiated with bullish view at Citizens JMP, here's why
3/12/2025 - The Fly
Cidara Therapeutics (CDTX, $22.39) price exceeded its 50-day Moving Average on March 10, 2025
3/11/2025 - Tickeron - Stocks
Cidara Therapeutics (CDTX, $22.39) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 10, 2025
3/11/2025 - Tickeron - Stocks
Cidara Therapeutics (CDTX, $22.39) price exceeded its 50-day Moving Average on March 10, 2025
3/11/2025 - Tickeron - Stocks
Cidara Therapeutics (CDTX, $22.39) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 10, 2025
3/11/2025 - Tickeron - Stocks
Cidara Therapeutics (NASDAQ:CDTX) Price Target Raised to $35.00
3/10/2025 - MarketBeat
Cidara Therapeutics price target raised to $35 from $24 at H.C. Wainwright
3/10/2025 - TipRanks Financial Blog
Cidara Therapeutics price target raised by $11 at H.C. Wainwright, here's why
3/10/2025 - The Fly
Cidara Therapeutics' (CDTX) "Buy" Rating Reaffirmed at Needham & Company LLC
3/8/2025 - MarketBeat
Cidara Therapeutics Faces Financial Risks Amid Delayed Annual Report Filing
3/8/2025 - TipRanks Financial Blog
Cidara Therapeutics Advances with Strong Financial Backing
3/8/2025 - TipRanks Financial Blog
Cidara Therapeutics (NASDAQ:CDTX) Releases Earnings Results, Misses Estimates By $0.10 EPS
3/7/2025 - MarketBeat
Cidara Therapeutics (CDTX, $23.61) entered Uptrend as Momentum indicator ascends above 0 level on Mar 06, 2025
3/7/2025 - Tickeron - Technical Analysis
Cidara Therapeutics (CDTX, $23.61) entered Uptrend as Momentum indicator ascends above 0 level on Mar 06, 2025
3/7/2025 - Tickeron - Stocks
Cidara Therapeutics (NASDAQ:CDTX) Receives Buy Rating from Needham & Company LLC
3/7/2025 - Ticker Report
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 ...
3/6/2025 - GuruFocus
Cidara Therapeutics GAAP EPS of -$5.37 misses by $1.52
3/6/2025 - SeekingAlpha.com: All News
Cidara Therapeutics reports Q4 EPS ($5.37) vs. (71c) last year
3/6/2025 - TipRanks Financial Blog
Cidara Therapeutics reports Q4 EPS ($5.37) vs. (71c) last year
3/6/2025 - The Fly
Cidara Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2024 Financial Results
3/6/2025 - Globe Newswire
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Sees Large Increase in Short Interest
3/6/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$4.03M
EBITDA (TTM)
-$45.59M
EBIT (TTM)
-$45.74M
Net Income (TTM)
-$120.73M
Balance Sheet
Total Assets (Q)
$162.33M
Total Debt (Q)
$3.94M
Total Liabilities (Q)
$46.70M
Book Value Per Share (Q)
$16.41
Cash Flow
Cash from Operations (TTM)
-$56.06M
Cash from Investing (TTM)
-$307.00K
Cash from Financing (TTM)
-$267.00K
Net Change in Cash (TTM)
-$56.64M
Filings
Filing Date
Thursday, November 7, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Apr 21 and 25 (est)
Price History
Loading...
Beta
0.42
7-Day Total Return
-2.68%
30-Day Total Return
26.27%
60-Day Total Return
4.16%
90-Day Total Return
75.68%
Year to Date Total Return
-17.44%
1-Year Total Return
69.47%
2-Year Total Return
-34.86%
3-Year Total Return
65.32%
5-Year Total Return
-50.79%
52-week Low
Apr 22, 2024 - $10.00
52-week High
Jan 02, 2025 - $28.42
Valuation
Market Cap
$251.93M - Micro Cap
Enterprise Value
$65.68M
Price/Sales (TTM)
37.27
Price/Book (Q)
1.40
Dividends and Shares
Shares Outstanding
6.53M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.cidara.com
Phone Number
858 752 6170
Address
6310 Nancy Ridge Drive
San Diego, CA 92121
Country
United States
Year Founded
2012
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Cidara Therapeutics, Inc., a biotechnology company, focuses on developing targeted therapies for patients facing cancers and other serious diseases. The company’s product includes rezafungin... more
NASDAQ 03/13/2025 10:16AM Eastern Quotes delayed
Weiss Ratings